期刊文献+

糖原合酶激酶3-β对胃癌细胞生长周期和转移的影响

Effect of GS K-3β on the cell cycle and metastasis of human gastric carcinoma cell
下载PDF
导出
摘要 目的:探讨GSK-3β功能改变对胃癌细胞生长周期和转移的影响。方法:LY294002单独或联合LiCl影响胃癌细胞株SCG-7901GSK-3β活性,Western blotting检测总GSK-3β、p-GSK-3βser9表达,MTT和FCM检测细胞增殖及周期分布,细胞免疫化学检测E-cadherin、β-catenin表达,细胞粘附实验观察细胞与基质的粘附力。结果:LY294002干预细胞72h后,总GSK-3β表达无改变,p-GSK-3βser9表达下降;增殖受抑制;细胞周期阻滞于G0/G1期;E-cadherin表达增高,β-catenin表达下降;细胞与基质粘附力降低。LiCl部分拮抗LY294002对细胞的生长抑制、周期阻滞及对E-cadherin、β-catenin表达的改变和细胞与基质粘附力的影响。结论:GSK-3β可促进胃癌细胞G1-S期周期阻滞、抑制细胞生长并可上调E-cadherin表达抑制细胞转移。 Objective: To observe the effect of GSK-3β on the cell cycle and metastasis of human gastric carcinoma cell. Methods: Influencing the GSK-3β activity of human gastric carcinoma cell line SCG-7901 by LY294002 with or with not LiCl treatment. The expression of total GSK-3β and p-GSK-3β^ser9 were detected in protein level by western blotting, cell proliferation and cell cycle distribution were tested by MTF and FCM respectively, the expression of E-cadherin and β-catenin were measured with S-P immunohistochemistry and the cell-ground substance adhesion was tested by cell adherence assay. Results: The expression of total GSK-3β was constant and the protein level of p-GSK-3β^ser9 was down regulated after exposured to LY294002 by 72 h,the cell proliferation was inhibited , cell cycle was arrest at G0/G1 phase,the E-cadherin level was positively regulated,the expression of β-catenin and the adhesion rate were decreased. The effect on the proliferation,cell cycle,the expression of E-cadherin and β -catenin and the adhesion by the LY294002 were partially abrogated by lithium chloride. Conclusion: GSK-3β could negatively regulate the proliferation of human gastric carcinoma cell by leading cells to GI-S arrest and inhibit its metastasis by positively regulating the expression of E-cadherin.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第4期405-408,共4页 Journal of Chongqing Medical University
关键词 糖原合酶激酶3-β 胃癌 细胞周期 E—cadherin Glycogen synthase kinase-3β Gastric carcinoma Cell cycle E-cadherin
  • 相关文献

参考文献12

  • 1Frame S,Cohen P. GSK3 takes centre stage more than 20 years after its discovery [J]. Biochem J, 2001,359 (Pt 1 ) : 1 - 16.
  • 2Cross D A, Alessi D R, Cohen P,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B[J]. Nature, 1995,378 (6559) : 785-789.
  • 3Vlahos C J, Matter W F, Hui K F, et al. A spceific inhibitor of phosphatidylinositol 3-kinase,2-(4-morpholinyl )-8-phenyl-4H- 1 -ben zopyran-4-one ( LY294002 ) [J]. J Biol Chem, 1994,269(7) : 5241-5248.
  • 4Ryves W J, Harwood A J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium[J]. Biochem Biophys Res Commun, 2001,280( 3 ) : 720-725.
  • 5金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 6Tsuchiya K, Nakamura T, Okamoto R,et al. Reciprocal targeting of Hath 1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer [J]. Gastroenterology, 2007,132( 1 ) : 208-220.
  • 7Thiel A, Heinonen M, Rintahanka J, et al. Expression of cycooxy genase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells [J]. J Biol Chem, 2006,281 ( 8 ) : 4564-4569.
  • 8Shakoori A,Ougolkov A,Yu Z W,et al. Deregulated GSK-3beta activity in colorectal cancer: its asscocitation with tumor cell survival and proliferation [J]. Biochem Biophys Res Commun, 2005,334(4) : 1365-1373.
  • 9Ougolkov A V,Fernandez-Zapico M E,Savoy D N,et al. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells[J]. Cancer Res, 2005,65 (6) : 2076-2081.
  • 10Dang J,Peng J,Zhang H,et al. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity[J]. Cancer Res,2005,65 ( 5 ) : 1961-1972.

二级参考文献9

  • 1Shimizu M,Saiton Y,Itoh H.Immunohistochemical staining of Ha-ras oncogene product in normal,bwnign and malignant human pancreatic tissues[J].Hum PATHOL,1990;21:607-612.
  • 2Gamallo C,Palacios J,Moreno G,et al.beta-catenin expression pattern in stage Ⅰ and Ⅱ ovarian carcinomas:relationship with beta-catenin gene mutations,clinico-pathological features,and clinical outcome[J].Am J Pathol,1999;155(2):527-536.
  • 3Moreno-Bueno G,Gamallo C,Perez-Grallego L,et al.beteCatenin expression pattern,bete-Catenin gene mutations,and microsatelliteinstability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas[J].Diagn MOL Pathol,2001;10(2):116-122.
  • 4Wu R,Zhai Y,Fearon ER,et al.Diverse mechanisms of beta-catenin Deregulation in Ovarian Endometrioid Adenocarcinomas[J].Cancer Res,2001 ;61 (22):8247-8255.
  • 5Karbova E,Davidson,Metodiev K,et al.Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma[J].Int J Surg Pathol,2002;10(3):175-180.
  • 6Jarrett CR,Blancoto J,Car T,et al.Humman APC2 Localization and Allelic Imbalame[J].Cancer Res,2001;61 (21):7978-7984.
  • 7Thliveris A,Samowitz W,Mastsunami N,et al.Demonstration of Promoter Activity and Alternative Splicing in the Region 5' to Exon 1 of the APC Gene[J].Cancer Res,1994;54(11):2991-2995.
  • 8Worsly SD,Ponder BA,Davies BR.Overexpression of Cyclin D1 in epithelial ovarian cancers[J].Gynecol Oncol,1997;64:189.
  • 9张明金,王强,王元和,许洪卫.大肠癌组织β-连环蛋白的表达及其临床意义[J].第二军医大学学报,2000,21(3):239-241. 被引量:5

共引文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部